InsiderFlow

CVKD

Cadrenal Therapeutics, Inc. Common Stock$2.36-0.06 (-2.48%)
Prev Close$2.42·MCap$18.7M·P/E·Vol46.2K·Yield

Buys (12M)

0

$0.00

Sells (12M)

23

$1.10M

Net Activity

Net Seller

$1.10M

Active Insiders

2

last 12 mo

Over the past 12 months, insider activity at Cadrenal Therapeutics, Inc. Common Stock (CVKD) has been exclusively selling, with 0 insider purchases totaling $0.00 and 23 insider sales totaling $1.10M. The most recent insider transaction was by Pham Quang X (director, 10 percent owner, officer: Chairman and CEO), who sold $22.4K worth of shares on Jul 1, 2026. Cadrenal Therapeutics, Inc. Common Stock operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $18.7M.

CVKD Insider Trading Activity

DateInsiderTypeValue
Jul 1, 2026 Pham Quang XSell$22.4K
Jun 26, 2026 Pham Quang XSell$33.9K
Jun 24, 2026 Pham Quang XSell$39.8K
Jun 18, 2026 Pham Quang XSell$13.1K
Jun 15, 2026 Pham Quang XSell$70.4K0.6% OS
Jun 10, 2026 Pham Quang XSell$93.3K0.8% OS
Jun 5, 2026 Pham Quang XSell$36.2K
Jun 2, 2026 Pham Quang XSell$3.1K
May 29, 2026 Pham Quang XSell$69.5K
May 26, 2026 Pham Quang XSell$6.6K
Dec 29, 2025 Szot Matthew KSell$69.2K
Oct 24, 2025 Pham Quang XSell$34.2K
Oct 24, 2025 Szot Matthew KSell$50.4K
Oct 9, 2025 Pham Quang XSell$50.7K
Oct 9, 2025 Szot Matthew KSell$49.0K
Oct 6, 2025 Szot Matthew KSell$1.5K
Oct 2, 2025 Pham Quang XSell$7.1K
Sep 29, 2025 Pham Quang XSell$18.2K
Sep 29, 2025 Szot Matthew KSell$25.2K
Sep 24, 2025 Pham Quang XSell$131.8K
Sep 24, 2025 Szot Matthew KSell$174.2K0.5% OS
Aug 27, 2025 Pham Quang XSell$70.4K
Aug 27, 2025 Szot Matthew KSell$28.0K
Oct 4, 2023 MURPHY JOHN RAYMONDBuy$14.0K0.9% OS
Sep 5, 2023 Pham Quang XBuy$36.2K1.7% OS
Sep 1, 2023 Pham Quang XBuy$63.9K3.0% OS
Mar 21, 2023 MURPHY JOHN RAYMONDBuy$13.9K
Mar 16, 2023 MURPHY JOHN RAYMONDBuy$33.4K0.9% OS

CVKD Insider Buying Activity

The following table shows recent insider purchases of Cadrenal Therapeutics, Inc. Common Stock (CVKD) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Oct 4, 2023 MURPHY JOHN RAYMONDBuy$14.0K0.9% OS
Sep 5, 2023 Pham Quang XBuy$36.2K1.7% OS
Sep 1, 2023 Pham Quang XBuy$63.9K3.0% OS
Mar 21, 2023 MURPHY JOHN RAYMONDBuy$13.9K
Mar 16, 2023 MURPHY JOHN RAYMONDBuy$33.4K0.9% OS

CVKD Insider Selling Activity

The following table shows recent insider sales of Cadrenal Therapeutics, Inc. Common Stock (CVKD) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Jul 1, 2026 Pham Quang XSell$22.4K
Jun 26, 2026 Pham Quang XSell$33.9K
Jun 24, 2026 Pham Quang XSell$39.8K
Jun 18, 2026 Pham Quang XSell$13.1K
Jun 15, 2026 Pham Quang XSell$70.4K0.6% OS
Jun 10, 2026 Pham Quang XSell$93.3K0.8% OS
Jun 5, 2026 Pham Quang XSell$36.2K
Jun 2, 2026 Pham Quang XSell$3.1K
May 29, 2026 Pham Quang XSell$69.5K
May 26, 2026 Pham Quang XSell$6.6K
Dec 29, 2025 Szot Matthew KSell$69.2K
Oct 24, 2025 Pham Quang XSell$34.2K
Oct 24, 2025 Szot Matthew KSell$50.4K
Oct 9, 2025 Pham Quang XSell$50.7K
Oct 9, 2025 Szot Matthew KSell$49.0K
Oct 6, 2025 Szot Matthew KSell$1.5K
Oct 2, 2025 Pham Quang XSell$7.1K
Sep 29, 2025 Pham Quang XSell$18.2K
Sep 29, 2025 Szot Matthew KSell$25.2K
Sep 24, 2025 Pham Quang XSell$131.8K
Sep 24, 2025 Szot Matthew KSell$174.2K0.5% OS
Aug 27, 2025 Pham Quang XSell$70.4K
Aug 27, 2025 Szot Matthew KSell$28.0K

CVKD Insiders

Pham Quang X

director, 10 percent owner, officer: Chairman, CEO and Interim CFO

Bought $100.1KSold $700.6K
18 tradesLast: Jul 1, 2026
Szot Matthew K

Chief Financial Officer

Sold $397.5K
7 tradesLast: Dec 29, 2025
MURPHY JOHN RAYMOND

Director

Bought $61.3K
3 tradesLast: Oct 4, 2023